Global telecom revolution: Spatial - Temporal aspects

195-212Current global telecommunication landscape is undergoing a paradigm change in terms of technologies and usage. <span style="color:black; mso-bidi-language:HI">Global System for Mobile (GSM) communications has emerged as the preferred technology followed by the fast growing Code Division Multiple Access (COMA) technology. Developed countries (without the transition countries) lead the world in number of landline and cellular connections, followed by high-income developing countries, which show the maximum growth. <span style="color:black; mso-bidi-language:HI">Paper also presents an analysis based on Digital Access Index (DAI) of the countries. India has emerged as a noteworthy participant in telecommunication market. Paper discusses techno-commercial and regulatory mechanism prevalent in the country. </span

Innovations in Indian Drug and Pharmaceutical Industry: Have they Impacted Exports?

243-252The paper examines the trends in exports, imports, R&D performance and patenting activities in regard of Indian drug and pharmaceutical industry for the period 2000-2012. Although most of the analysis, drawing upon different databases, is of descriptive nature, it also estimates functional relationship between exports as dependent variable and patents granted and R&D expenditure as independent variables. The study found that lagged R&D expenditure and lagged total patents granted affect exports positively and significantly. It suggests encouragement to public-private R&D partnership in the realm of basic and applied research, which could be commercially harnessed by the interested private sector partner(s). </span

Innovations in Indian Drug and Pharmaceutical Industry: Have they impacted Exports?

The paper examined the trends in exports, imports, R&amp;D performance and patenting activity in the Indian drug and pharmaceutical industry for a period 2000-2012. Although most of the analysis is of descriptive nature drawing upon different databases, it also estimates the functional relationship between exports as dependent variable with patents granted and R&amp;D expenditure as independent variable through OLS regression. The OLS model found that lagged R&amp;D expenditure and lagged total patents granted affect exports positively and significantly due to innovations carried out across different drug classes and treatment categories. The Indian firms have also been found to be recording a relatively steady growth in patent filing except for Ranbaxy which has experienced a sharp decline in patent output after 2006 because of increasing cases of litigations for the infringement of patent rights of other pharma majors